LyGenesis

United States
Mantua, Ohio, United States

Company profile

LyGenesis company profile

LyGenesis is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Their initial target organ for clinical development is liver regeneration, with a focus on helping patients with end stage liver disease (ESLD).

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2017-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
4
Total equity funding
$22M
Last funding
Series A / $19M / 2023-10-24
Last equity funding
Series A / $19M
Investors
3
Lead investors
3
Founders
1
Articles
42

Founders and investors

Founders

Michael Hufford

Lead investors

JuvenescenceLongevity Vision FundPrime Movers Lab

Investors

JuvenescenceLongevity Vision FundPrime Movers Lab